RT Journal Article
SR Electronic
T1 A More Accurate Measurement of COVID-19 Hospitalizations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.03.22275891
DO 10.1101/2022.06.03.22275891
A1 Vu, Christina
A1 Kawaguchi, Eric S.
A1 Torres, Cesar H.
A1 Lee, Austin H.
A1 Stafylis, Chrysovalantis
A1 Klausner, Jeffrey D.
A1 Khan, Saahir
YR 2022
UL http://medrxiv.org/content/early/2022/06/05/2022.06.03.22275891.abstract
AB COVID-19 hospitalizations are a key indicator of the SARS-CoV-2 pandemic. The US Centers for Disease Prevention and Control describes oxygen supplementation as a measure of severe disease. SARS-CoV-2 PCR positive patients hospitalized without hypoxia or requiring oxygen may have been identified incidentally due to routine screening practices. We describe the application of a revised case definition for COVID-19 hospitalization based on the case-patient oxygen requirement on admission. Using data collected from consecutive SARS-CoV-2 PCR positive hospital admissions in December 2021 and January 2022 at a large safety net hospital in Los Angeles County, we highlight differences between patients hospitalized with COVID-19 (i.e., no oxygen requirement on admission or `incidental` infection) and those hospitalized for COVID-19 (i.e., oxygen requirement on admission). We conducted multivariable modeling to determine the effect of age as a positive predictor of COVID-19 hospitalization and vaccination or prior infection as a negative predictor. The revised case-definition resulted in a substantial decrease in the number of COVID-19 hospitalizations during the study period: 67.5% of SARS-CoV-2 PCR positive hospital admissions were not for COVID-19 but with COVID-19. A revised case-definition for COVID-19 hospitalization that includes the oxygen requirement on admission is needed to more accurately monitor the pandemic and inform public health policy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the William H. Keck Foundation and the COVID-19 Pandemic Research Center of the Keck School of Medicine of the University of Southern California.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of University of Southern California gave ethical approval for this work under Protocol HS-20-00880 Contact: 3720 S. Flower Street, Suite 325 Los Angeles, CA 90089IRB{at}usc.eduI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors